Genomictree Inc. (KOSDAQ:228760)

Genomictree Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26,350	45,269	67,572	66,461	56,641
Short-Term Investments	69,730	47,877	47,033	64,081	46,478
Cash & Short-Term Investments	96,080	93,146	114,605	130,542	103,119
Cash Growth	3.15%	-18.72%	-12.21%	26.59%	2.80%
Accounts Receivable	332.5	388.29	1,031	2,267	128.37
Other Receivables	274.54	286.19	144.11	28.22	148.98
Receivables	607.04	674.47	1,175	2,295	277.36
Inventory	334.58	496.53	635.45	284.87	1,231
Prepaid Expenses	105.9	395.89	424.22	502.98	416.53
Other Current Assets	534.92	657.95	1,160	702.45	255.99
Total Current Assets	97,662	95,371	118,000	134,327	105,300
Property, Plant & Equipment	18,386	17,460	17,866	21,459	10,633
Long-Term Investments	6,430	14,048	21,136	19,656	969.4
Other Intangible Assets	1,250	1,336	1,470	1,523	752.73
Long-Term Deferred Charges	0	20.92	83.67	146.43	209.19
Other Long-Term Assets	6,947	4,608	4,354	40.12	30.88
Total Assets	130,675	132,844	162,910	177,151	117,896
Accounts Payable	66.89	66.79	132.6	87.57	83.8
Accrued Expenses	1,445	1,433	1,821	441.27	341.7
Short-Term Debt	1,972	1,690	29,043	-	-
Current Portion of Long-Term Debt	0	0	0	-	80
Current Portion of Leases	47.42	47.42	52.8	265.79	204.62
Current Income Taxes Payable	-	-	1.7	-	-
Current Unearned Revenue	1.03	0.64	9.8	28.6	15
Other Current Liabilities	1,218	2,044	22,381	1,319	3,364
Total Current Liabilities	4,751	5,281	53,442	2,142	4,090
Long-Term Debt	-	-	-	37,271	10,332
Long-Term Leases	59.98	97.52	84.63	907.61	929.65
Long-Term Deferred Tax Liabilities	92.97	92.97	579.61	206.6	206.6
Other Long-Term Liabilities	33.78	49.94	44.39	18,770	4,735
Total Liabilities	6,356	7,812	55,353	62,050	22,640
Common Stock	12,181	12,006	10,513	10,164	9,993
Additional Paid-In Capital	85,935	79,972	57,050	55,819	118,518
Retained Earnings	20,602	31,274	39,976	46,434	-32,310
Treasury Stock	-4,878	-4,984	-4,984	-	-
Comprehensive Income & Other	10,045	6,468	4,345	2,296	-945.99
Total Common Equity	123,885	124,736	106,900	114,713	95,255
Minority Interest	434.79	295.48	502.28	-	-
Shareholders' Equity	124,320	125,032	107,557	115,101	95,255
Total Liabilities & Equity	130,675	132,844	162,910	177,151	117,896
Total Debt	2,079	1,835	29,180	38,444	11,546
Net Cash (Debt)	94,001	91,312	85,425	92,098	91,573
Net Cash Growth	2.94%	6.89%	-7.25%	0.57%	-7.60%
Net Cash Per Share	3936.62	3444.88	4069.68	4461.03	4581.82
Filing Date Shares Outstanding	23.99	23.63	20.65	20.33	19.99
Total Common Shares Outstanding	23.99	23.63	20.65	20.33	19.99
Working Capital	92,912	90,090	64,557	132,185	101,211
Book Value Per Share	5163.99	5278.29	5177.78	5643.25	4766.06
Tangible Book Value	122,635	123,400	105,429	113,190	94,503
Tangible Book Value Per Share	5111.89	5221.76	5106.57	5568.33	4728.39
Land	7,699	7,981	7,924	9,612	4,632
Buildings	5,703	6,167	6,100	8,064	2,295
Machinery	8,775	6,102	6,016	4,524	4,083
Construction In Progress	363.59	326.11	133.2	138.2	1.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.